Fab-P1-1013

N/A

Report date: 2023/08/08 17:45:50

Base Information

Drug NameFab-P1-1013

Drug Alias NameFab-P1-1013

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionIgE Fc receptor, alpha-subunit antagonists

TargetsIgE Fc receptor, alpha-subunit

Therapy Area/IndicationsHypersensitivity, Immediate

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesFatiAbGen Corp

China Registration ClassN/A

Active CompaniesFatiAbGen Corp

Inactive CompaniesN/A

Active IndicationsHypersensitivity, Immediate

Inactive IndicationsN/A

ATC CodeN/A